<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02825511</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX 2014/18</org_study_id>
    <nct_id>NCT02825511</nct_id>
  </id_info>
  <brief_title>Assessment of the Clinic-pathological Correlation of Basal Cell Carcinoma</brief_title>
  <acronym>CAC-CBC</acronym>
  <official_title>Assessment of the Clinic-pathological Correlation of Basal Cell Carcinoma: Establishment of a Prospective Observational Cohort and Followed 3 Years</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Société de Dermatologie Française</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assessment of the concordance of the initial clinical and histological diagnosis and to
      explore its prognostic impact in terms of risk of recurrence.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The skin cancer is a major public health problem whose incidence is increasing due to the
      aging population. Among them, basal cell carcinoma (BCC) is a daily concern the
      dermatologist. The recommendation of good practice for the BCC of support has been
      established according to French agency methodology in 2004 : &quot;Agence Nationale
      d'Accréditation et d'Evaluation en Santé&quot; (ANAES). This classification is based on clinical
      and pathological use of sometimes mismatched terminology pretending to clinical reality with
      discrepancies between the clinical appearance and histology. On the other hand the simplified
      classification of recommendations has never been tested and validated on a large series of
      BCC. Probabilistic margins applied based on clinical assessment of clinical and pathological
      subtype, it seems interesting to evaluate the consistency of the initial clinical diagnosis
      and histological diagnosis and to explore its prognostic impact in terms of risk of
      recurrence.

      This study could lead to improved clinical and pathological classification and allow amending
      the current recommendations of the surgical management of the BCC.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Dimension of basal cell carcinoma.</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of clinical type of basal cell carcinoma (nodular, superficial or sclerodermiform)</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of histological type of basal cell carcinoma (nodular, superficial, infiltrating or sclerodermiform)</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of the disease according to region (head, leg, arm, eyelid, lip,...)</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical aggressiveness Score with &quot;Agence Nationale d'Accréditation et d'Evaluation en Santé&quot; (ANAES) criteria</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">2738</enrollment>
  <condition>Basal Cell Carcinoma</condition>
  <arm_group>
    <arm_group_label>A cohort of basal cell carcinoma</arm_group_label>
    <description>A cohort of surgically treated BCC, primitive clinically suspected or previously biopsied on a 4-month period, an expected number of 3 200 cases. The management of the BCC will be consistent with current recommendations. BCC recurrence and those who received prior medical treatment will be excluded.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        BCC primitive, clinically suspected or previously biopsied
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primitive BCC

          -  BCC clinically suspected or previously biopsied

          -  Supports conventional surgical or micrographic techniques.

          -  Patient able to sign a consent after reading the briefing note

        Exclusion Criteria:

          -  Recurrent CBC

          -  prior medical treatment

          -  BCC assigned to another operator for removal

          -  Genodermatosis underlying (xeroderma pigmentosum - Gorlin syndrome)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean Michel AMICI, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Bordeaux</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wiart (Dermatologue - Armentieres)</name>
      <address>
        <city>Armentieres</city>
        <zip>59280</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dupin (Dermatologue - Auch)</name>
      <address>
        <city>Auch</city>
        <zip>32000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Bordeaux - Hospital Saint André</name>
      <address>
        <city>Bordeaux</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Will (Dermatologue - Brumath)</name>
      <address>
        <city>Brumath</city>
        <zip>67170</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ruto (Dermatologue - Evreux)</name>
      <address>
        <city>Evreux</city>
        <zip>27000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jacquet (Dermatologue - Hyeres)</name>
      <address>
        <city>Hyeres</city>
        <zip>83400</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tranchand (Dermatologue - Le Puy En Velay)</name>
      <address>
        <city>Le Puy En Velay</city>
        <zip>43000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier de L'Institut Catholique de Lille</name>
      <address>
        <city>Lille</city>
        <zip>51000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bacconier (Dermatologue - Marseille)</name>
      <address>
        <city>Marseille</city>
        <zip>130005</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Haberstroh (Dermatologue - Mulhouse)</name>
      <address>
        <city>Mulhouse</city>
        <zip>68100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bolzinger (Dermatologue - Nay)</name>
      <address>
        <city>NAY</city>
        <zip>64800</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Nice</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chaussade (Dermatologue - Paris)</name>
      <address>
        <city>Paris</city>
        <zip>75000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tanguy (Dermatologue - Pau)</name>
      <address>
        <city>PAU</city>
        <zip>64000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bailly (Dermatologue - Toulouse)</name>
      <address>
        <city>Toulouse</city>
        <zip>31000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chu de Toulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lulin (Dermatologue - Vendome)</name>
      <address>
        <city>Vendome</city>
        <zip>41100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 4, 2016</study_first_submitted>
  <study_first_submitted_qc>July 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 7, 2016</study_first_posted>
  <last_update_submitted>July 15, 2016</last_update_submitted>
  <last_update_submitted_qc>July 15, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>basal cell carcinoma, histological diagnosis, prognostic impact</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Basal Cell</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

